6936 — Vetnostrum Animal Health Co Income Statement
0.000.00%
- TWD2.52bn
- TWD2.44bn
- TWD1.29bn
- 95
- 51
- 63
- 82
Annual income statement for Vetnostrum Animal Health Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,105 | 1,176 | 1,185 | 1,208 | 1,294 |
Cost of Revenue | |||||
Gross Profit | 342 | 357 | 353 | 357 | 441 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 970 | 1,040 | 1,061 | 1,096 | 1,123 |
Operating Profit | 135 | 137 | 125 | 112 | 171 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 131 | 134 | 131 | 113 | 170 |
Provision for Income Taxes | |||||
Net Income After Taxes | 104 | 110 | 107 | 91.6 | 137 |
Net Income Before Extraordinary Items | |||||
Net Income | 104 | 110 | 107 | 91.6 | 137 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 104 | 110 | 107 | 91.6 | 137 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 1.66 | 1.68 | 1.38 | 2.08 |
Dividends per Share |